Helicobacter Pylori Testing Market 2022
According to MRFR analysis, Helicobacter Pylori Testing Market is expected to register a CAGR of 5.2% during the forecast period of 2019 to 2025 and is expected to reach USD 2,924.2 Million by 2025. Helicobacter pylori infection occurs when the H. pylori bacteria infects the stomach. Some of the major factors driving the market growth are the growing burden of H. pylori infections and dyspepsia, availability of diagnostic tests, the presence of a cost-effective diagnosis of H. pylori, and globally surging target patient population. Dyspepsia is a condition associated with gastrointestinal (GI) disease, with a worldwide prevalence of around 20%. H. pylori-associated diseases are commonly present with dyspepsia. On the contrary, low diagnosis rates of helicobacter pylori infection in developing nations is anticipated to limit the market growth during the review period.
Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/helicobacter-pylori-test-market-8497
Major Key Players:
Some of the key players in the Global H. Pylori Test Market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Quest Diagnostics Incorporated (US), F. Hoffmann-La Roche Ltd (Switzerland), Meridian Bioscience (US), CorisBioconcept SPRL (Belgium), Cardinal Health (US), Abbott Laboratories (US), QIAGEN (Germany), and Biohit Oyj (Finland).
The Helicobacter Pylori Testing Market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The H. Pylori Test Market in the Americas has further been segmented into North America and Latin America, with the North American market segregated into the US and Canada. The existence of prominent market players and advanced healthcare infrastructure in the US and Canada is assisting the dominance of the North American market. The European H. Pylori Test Market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The H. Pylori Test Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is likely to register the fastest market growth during the forecast period owing to the presence of target population base, growing awareness about H. pylori and its diagnosis, and increasing per capita health expenditure in India, China, and Japan.
The H. Pylori Test Market in the Middle East & Africa has been bifurcated into the Middle East and Africa.
The Global H. Pylori Test Market has been segmented based on test type, technology, and end-user.
Based on the test type, the market has been divided into non-endoscopic and endoscopic. The non-endoscopic segment has been further classified as stool/fecal antigen test (SAT), urea breath test (UBT), and serology/antibody/blood test. The endoscopic segment is additionally categorized into culture, histology, rapid urease/campylobacter-like organism (CLO) test, and polymerase chain reaction (PCR). Urea breath test and stool (fecal) antigen tests are preferred for the diagnosis of H. pylori infection and evaluate the effectiveness of treatment, which is contributing to the dominance of the non-endoscopic segment.
On the basis of technology, the global H. Pylori Test Market has been divided into immunoassays, point-of-care (POC), and molecular diagnostics. Molecular methods are widely used for the diagnosis of H. pylori and to analyze diversity, virulence, and resistance patterns of these bacteria. This has contributed to the segment’s second-largest position in 2018.
By end-user, the market has been bifurcated into hospitals and clinics, diagnostics laboratories, and others. The hospitals and clinics segment would hold a substantial revenue share during the assessment period attributed to facts that increase in the number of H. pylori test procedures performed in these healthcare settings.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312